Prognostic and predictive biomarkers in prostate cancer
- 7 November 2015
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Molecular Diagnostics
- Vol. 15 (12) , 1567-1576
Abstract
Prognostic and predictive biomarkers in prostate cancer. . ???aop.label???. doi: 10.1586/14737159.2015.1110022Keywords
This publication has 76 references indexed in Scilit:
- Novel Membrane-associated Androgen Receptor Splice Variant Potentiates Proliferative and Survival Responses in Prostate Cancer CellsJournal of Biological Chemistry, 2011
- Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancerBritish Journal of Cancer, 2009
- Change in Markers of Bone Metabolism with Chemotherapy for Advanced Prostate Cancer: Interleukin-6 Response Is a Potential Early Indicator of Response to TherapyJournal of Interferon & Cytokine Research, 2009
- TGFβ in CancerCell, 2008
- Recurrent gene fusions in prostate cancerNature Reviews Cancer, 2008
- Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patientsBritish Journal of Cancer, 2008
- Secreted frizzled related protein 1 is a paracrine modulator of epithelial branching morphogenesis, proliferation, and secretory gene expression in the prostateDevelopmental Biology, 2008
- Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancerBritish Journal of Cancer, 2007
- Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activityProceedings of the National Academy of Sciences, 2007
- Role of the stromal microenvironment in carcinogenesis of the prostateInternational Journal of Cancer, 2003